Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment

Author:

Feichtenschlager Valentin12,Zheng Yixuan James13,Ho Wilson1,Chen Linan1,Callanan Ciara1,Chen Christopher1,Lee Albert1,Ortiz Jose1,Rappersberger Klemens2,Ortiz-Urda Susana1

Affiliation:

1. Department of Dermatology, Mt Zion Cancer Research Center, University of California San Francisco, San Francisco, CA 94110, USA

2. Department of Dermatology, Clinic Landstrasse Vienna, Academic Teaching Hospital, Medical University Vienna, Vienna, Austria

3. School of Medicine, University of California San Francisco, San Francisco, CA 94110, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Reference67 articles.

1. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Populations - Total U.S. (1969-2019) - Linked To County Attributes - Total U.S., 1969-2019 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released December 2020.

2. The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy;Hu;J Hematol Oncol,2020

3. Author Correction: Trends in kinase drug discovery: targets, indications and inhibitor design;Schiöth;Nat Rev Drug Discov,2021

4. Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail;Robertson;Biochem Pharmacol,2010

5. Principles and innovative technologies for decrypting noncoding RNAs: from discovery and functional prediction to clinical application;Chen;J Hematol Oncol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3